Beatriz Felicio Ribeiro

CV Lattes

Universidade Estadual de Campinas (UNICAMP). Centro de Hematologia e Hemoterapia (HEMOCENTRO) (Institutional affiliation from the last research proposal)
Birthplace: Brazil

Beatriz Felicio Ribeiro in research grants and scholarships supported by FAPESP.

News published in Agência FAPESP Newsletter about the researcher

More items Less items

TITULO

Articles published in other media outlets ( ):

More items Less items

VEICULO: TITULO (DATA)

Scholarships in Brazil

Completed (most recent)

Abstract
Chronic myeloid leukemia (CML) is a chronic myeloproliferative disorder characterized by the presence of Philadelphia (Ph) and production of the BCR-ABL fusion protein, with constitutive tyrosine kinase activity. Imatinib is currently the first line treatment approved for CML in Brazil. In spite of high response rates, some patients are resistant or intolerant to treatment, and need to sw…
Evaluation of molecular response and expression of ABCF2, ALOX15B, PAWR, ncFOXO3A, ncMYLIP and ncSLC44A2 genes in patients with chronic myeloid leukemia treated with second generation tyrosine kinase inhibitors, BP.MS

Virtual Library in numbers * Updated data on August 30, 2025

Total / Available in English

1 / 1	Completed scholarships in Brazil

Associated processes

Most frequent collaborators in research granted by FAPESP

Katia Borgia Barbosa Pagnano

Keywords used by the researcher

Health Sciences Medicine

Please report errors on the page using this form.

Short URL

Abstract